Metformin Adherence and effect of reduction of dosing frequency in type 2 diabetes

Metformin Adherence and effect of reduction of dosing frequency in type 2 diabetes - metformin adherence study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031677

Enrollment

200

Registered

2018-03-12

Start date

2018-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: <study1> Type 2 diabetes who use twice daily metformin <study2> Type 2 diabetes who use twice daily 500mg metformin and conventional dosage DPP4 inhibitor

Exclusion criteria

Exclusion criteria: (1)the patients whose antidiabetes medication was changed within 2 month (2)the patients who reject the study participation

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Secondary

Measure	Time frame
change of daily glucose fluctuation measured by Flash glucose monitoring, medication adherence scale for patients with chronic disease in Japan, Medication possession ratio.	—

Countries

Japan

Contacts

Public ContactSaeko Osawa

Osaka kaisei hospital department of diabetes care medicine

s-osawa@umin.ac.jp0663936234

Outcome results